2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose
CAS: 68567-47-5
Ref. 3D-MB167649
| 1mg | 356.00 € | ||
| 5mg | 1,133.00 € | ||
| 10mg | 1,813.00 € |
Product Information
2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose (BTDG) is a nitro derivative of L-threonine that has been derivatized with an acetyl group and a molecule of 2,4,6-trideoxygalactose. BTDG has been shown to be safe in clinical trials for vaccine development against life-threatening diseases. It is the first glycopolymer approved by the FDA for clinical use in humans. This drug has been shown to increase the antibody response and improve protection against influenza virus infection. BTDG also inhibits bacterial replication by blocking protein synthesis in some bacteria and inhibiting glycolysis in others.
Chemical properties
Technical inquiry about: 3D-MB167649 2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
